Mannatech Inc.
MTEX Real Time Price USDRecent trades of MTEX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MTEX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same Nov. 06, 2018
-
Patent Title: Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same Jan. 02, 2018
-
Patent Title: Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same Aug. 16, 2016
-
Patent Title: Antioxidant compositions and methods thereto Jul. 31, 2012
-
Patent Title: Rapid serum sugar biomarker assay of rheumatoid arthritis May. 08, 2012
-
Patent Title: Antioxidant compositions and methods thereto Aug. 16, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of MTEX in WallStreetBets Daily Discussion
Recent insights relating to MTEX
Recent picks made for MTEX stock on CNBC
ETFs with the largest estimated holdings in MTEX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MTEX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.